TrialSignal
Clinical trial intelligence report
Stoma Closure and Reinforcement (SCAR)-II Trial: A Single Center Pilot Study of the Safety of a Mesh Reinforcement of Ileostomy Closure to Prevent Hernia Formation in Inflammatory Bowel Disease Patients
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT04916067
Status
TERMINATED
Phase
Pilot Study (terminated)
Sponsor
Dartmouth-Hitchcock Medical Center
Executive brief
Investment-Ready Snapshot
The SCAR-II trial aimed to evaluate the safety and effectiveness of a bioresorbable mesh reinforcement technique during ileostomy closure in patients with inflammatory bowel disease. The study was conducted at Dartmouth-Hitchcock Medical Center but was terminated early due to resource constraints, with only 8 participants enrolled.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT04916067
Indication
Ileostomy - Stoma
Modality
protein therapy
Target
Hernia formation prevention in ileostomy closure
Intervention
Mesh Implantation
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.